Evidence map›Paper›PMID 39032166›Full record

ArticleClinical and translational medicine2024

Cancer-associated fibroblasts mediate resistance to neoadjuvant therapy in breast cancer.

Zihan Xia, Stephanie Vermeulen, Ujjwal Suwal, Pekka Rappu, Jyrki Heino, Felix De Vuyst, Sandor Dedeyne, An Hendrix, Hannelore Denys, Olivier De Wever

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Resistance to neoadjuvant chemotherapy in breast cancers: a metabolic perspective.Journal of experimental & clinical cancer research : CR · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zihan XiaDepartment of Human Structure and Repair, Laboratory of Experimental Cancer Research, Ghent University, Ghent, Belgium.ORCID 0009-0001-1935-2183
Stephanie VermeulenDepartment of Human Structure and Repair, Laboratory of Experimental Cancer Research, Ghent University, Ghent, Belgium.ORCID 0000-0002-9655-2293
Ujjwal SuwalDepartment of Life Technologies, University of Turku, Turku, Finland.
Pekka RappuDepartment of Life Technologies, University of Turku, Turku, Finland.ORCID 0000-0002-5068-2842
Jyrki HeinoDepartment of Life Technologies, University of Turku, Turku, Finland.
Felix De VuystDepartment of Human Structure and Repair, Laboratory of Experimental Cancer Research, Ghent University, Ghent, Belgium.
Sandor DedeyneDepartment of Human Structure and Repair, Laboratory of Experimental Cancer Research, Ghent University, Ghent, Belgium.
An HendrixDepartment of Human Structure and Repair, Laboratory of Experimental Cancer Research, Ghent University, Ghent, Belgium.
Hannelore DenysCancer Research Institute Ghent, Ghent, Belgium.
Olivier De WeverDepartment of Human Structure and Repair, Laboratory of Experimental Cancer Research, Ghent University, Ghent, Belgium.

Funding

China Scholarship Council 202006160045Concerted Research Actions of Ghent UniversityKom Op Tegen KankerStichting Tegen Kanker
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Breast NeoplasmsCancer-Associated FibroblastsDrug Resistance, NeoplasmNeoadjuvant TherapyFemaleHumans

Identifiers

PMID39032166
PMCPMC11260170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.